4:00 pm EST - 5:00 pm EST

Past Event

Brookings Roundtable on Active Medical Product Surveillance: Learnings from H1N1 Vaccine Surveillance

Thursday, December 03, 2009

4:00 pm - 5:00 pm EST

The Brookings Institution
Teleconference Call

1775 Massachusetts Ave., NW
Washington, DC

This roundtable teleconference featured a presentation from i3 Drug Safety President Terri Madison, who provided an overview of the organization’s self-sponsored H1N1 vaccine safety surveillance program and preliminary results, including lessons learned.

A moderated question and answer period followed the presentation.

Convened by the Engelberg Center for Health Care Reform at Brookings, roundtable teleconferences provide a forum to discuss public and private initiatives in which methods, data sources, and technology related to active medical product safety surveillance are being developed. These roundtables are intended to engage a broad range of stakeholders in productive discussions that reflect the current state and growing activity around medical product surveillance.